These results suggest that COX-2 inhibitors may increase radiosensitivity, and this effect has been shown in tumor cells; however, COX-2 inhibitors also damaged normal proliferating cells, including the intestinal tract. This evidence concerns the gene PTGS2 and neoplasm.